A carregar...

Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.

The efficacy of gemfibrozil in lowering increased serum lipoprotein concentrations was tested in a placebo-controlled cross-over trial on 30 patients. Administered in a dose of 1200 mg daily, gemfibrozil reduced increased serum triglyceride levels by approximately 50% and reduced increased serum cho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vessby, B., Lithell, H., Boberg, J., Hellsing, K., Werner, I.
Formato: Artigo
Idioma:Inglês
Publicado em: 1976
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1864027/
https://ncbi.nlm.nih.gov/pubmed/798194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!